Ida Adeli

439 total citations · 1 hit paper
2 papers, 250 citations indexed

About

Ida Adeli is a scholar working on Pharmacology, Public Health, Environmental and Occupational Health and Psychiatry and Mental health. According to data from OpenAlex, Ida Adeli has authored 2 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 1 paper in Pharmacology, 1 paper in Public Health, Environmental and Occupational Health and 1 paper in Psychiatry and Mental health. Recurrent topics in Ida Adeli's work include Ovarian cancer diagnosis and treatment (1 paper), Ovarian function and disorders (1 paper) and Reproductive Biology and Fertility (1 paper). Ida Adeli is often cited by papers focused on Ovarian cancer diagnosis and treatment (1 paper), Ovarian function and disorders (1 paper) and Reproductive Biology and Fertility (1 paper). Ida Adeli collaborates with scholars based in Iran, Romania and Greece. Ida Adeli's co-authors include Mohammad Abdollahı, Marzieh Daniali, Shekoufeh Nikfar, Taraneh Mousavi, Anca Oana Docea, Daniela Călina and Aristidis Tsatsakis and has published in prestigious journals such as International Journal of Molecular Sciences and Life.

In The Last Decade

Ida Adeli

2 papers receiving 245 citations

Hit Papers

Polycystic Ovary Syndrome: A Comprehensive Review of Path... 2022 2026 2023 2024 2022 50 100 150 200

Peers

Ida Adeli
Xi Luo China
Ida Adeli
Citations per year, relative to Ida Adeli Ida Adeli (= 1×) peers Xi Luo

Countries citing papers authored by Ida Adeli

Since Specialization
Citations

This map shows the geographic impact of Ida Adeli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ida Adeli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ida Adeli more than expected).

Fields of papers citing papers by Ida Adeli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ida Adeli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ida Adeli. The network helps show where Ida Adeli may publish in the future.

Co-authorship network of co-authors of Ida Adeli

This figure shows the co-authorship network connecting the top 25 collaborators of Ida Adeli. A scholar is included among the top collaborators of Ida Adeli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ida Adeli. Ida Adeli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

2 of 2 papers shown
1.
Adeli, Ida, Daniela Călina, Anca Oana Docea, et al.. (2022). Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing. International Journal of Molecular Sciences. 23(2). 583–583. 230 indexed citations breakdown →
2.
Adeli, Ida, et al.. (2021). Drug Repurposing for the Management of Depression: Where Do We Stand Currently?. Life. 11(8). 774–774. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026